Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.
AUTOR(ES)
Tishler, M
RESUMO
Seventy-four Israeli patients with rheumatoid arthritis (RA) were studied for possible association between HLA antigens and adverse reactions to gold treatment (aurothioglucose). HLA-B35 was significantly increased in patients who developed gold induced mucocutaneous lesions. These results are in accord with earlier reports, despite the different genetic background of the Israeli RA population and the different type of gold compound used.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003486Documentos Relacionados
- Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
- HLA-B27 in Turkish patients with rheumatoid arthritis.
- HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
- Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
- Distribution of HLA-B27 in patients with juvenile rheumatoid arthritis.
